In the past, aspirin has been used as a potent drug to treat mild to moderate pain as well as reduce fever or inflammation. However, recent studies have shown that administration of low-dose aspirin can aid in the prevention of cancer in middle-aged adults. In fact, it may take only 2 to 3 years for the drug to act upon the cells that may have a high tendency to turn malignant. Key research studies have also discovered that aspirin may lower the chance of metastasis in cancer patients. Currently, medical investigators are seeking government’s help to raise awareness about the importance of aspirin therapy.
One of the world’s top medical researchers, Professor Peter Rothwell of the Nuffield Department of Clinical Neurosciences at Oxford University in the UK, and colleagues, have conducted these studies and published them in The Lancet and The Lancet Oncology. Nevertheless, previously published articles have explained that many cancer patients may take nearly 8 to 10 years to respond to this medication. But new clinical findings have clearly stated the rapid effects of aspirin on the cancer cells.
The drug is highly efficacious in the early stage of the disorder. Further clinical trials can however, confirm the effectiveness of aspirin in treating the dreadful ailment. Like any other drug, aspirin also has a host of side effects that cannot be ruled out by the doctors. Rothwell and colleagues agree that repeated use of aspirin can lead to abdominal bleeding, but it is normally less pronounced and not life-threatening. It should also be kept in mind that the degree of severity is quite high in the case of cancer than mild to moderate internal bleeding.
Individuals who are at a greater risk of having a stroke or a heart attack can also resort to aspirin. According to Rothwell, colorectal cancer and oesophageal cancer have greatly benefitted from this drug compared to the other types of the disease. In all likelihood, aspirin is a highly useful drug with less severe side effects.